Polarean Imaging PLC (AIM:POLX, OTC:PLLWF) has appointed Daniel Brague, already a non-executive director, as a consultant to the company providing strategic advice to the commercial team, as its marketing and sales plans are being refined.
Brague provides “significant experience in the commercialisation of innovative medical imaging products worldwide", the company said.
"I am a strong believer in the potential of XENOVIEW to meet the clinical need for a non-invasive diagnostic technology for the over 30 million Americans that suffer from a chronic lung disease,” Brague said.